A Phase 3, Multicenter, Randomized, Double-blind Study to Evaluate the Interchangeability of V114 and Prevnar 13¿ with Respect to Safety, Tolerability, and Immunogenicity in Healthy Infants (PNEU-DIRECTION)

Project: Research project

Project Details

StatusFinished
Effective start/end date9/14/18 → 9/13/21

Funding

  • Merck Sharp and Cohme Corporation: $8,250.00